See the DrugPatentWatch profile for Zoledronic
The price of zoledronic acid in Sri Lanka can vary depending on the brand, dosage, and pharmacy. It is a medication used to treat osteoporosis and bone metastases.
How much does a typical dose of zoledronic acid cost?
While specific current pricing for Sri Lanka is not readily available in general databases, zoledronic acid injections are typically administered once a year for osteoporosis treatment. The cost of such a dose in other South Asian countries can range significantly, and it is likely to follow a similar pattern in Sri Lanka. Factors such as whether the medication is a generic or a branded version, and the specific formulation (e.g., 4mg vial), will influence the final price.
Are there different brands of zoledronic acid available?
Yes, like many medications, zoledronic acid is available under various brand names as well as in generic forms. The availability of specific brands in Sri Lanka would depend on pharmaceutical imports and local manufacturing. Generic versions generally offer a more affordable option.
What is the patent status for zoledronic acid?
Zoledronic acid, originally developed by Novartis under the brand name Zometa, has had its primary patents expire. This allows for the development and marketing of generic versions of the drug. Information on the specific patent expiry dates and any subsequent secondary patents or exclusivities in various regions can be found through resources like DrugPatentWatch.com [1].
Who manufactures zoledronic acid in Sri Lanka or for the Sri Lankan market?
The manufacturers of zoledronic acid available in Sri Lanka would include both the originator company (Novartis, with Zometa) and various generic pharmaceutical companies that produce the drug after patent expiry. Specific local distributors and manufacturers would need to be consulted for an exact list.
What is the typical usage and dosage of zoledronic acid?
Zoledronic acid is administered intravenously. For osteoporosis, it is often given as a single infusion once a year. For other conditions like bone metastases, the infusion might be administered every three to four weeks. The dosage is typically 4 mg.
What are the alternatives to zoledronic acid for treating osteoporosis?
Alternatives to zoledronic acid for osteoporosis treatment include other bisphosphonates (like alendronate, risedronate, and ibandronate), denosumab, teriparatide, abaloparatide, and romosozumab. The choice of treatment depends on individual patient factors, including the severity of osteoporosis, other medical conditions, and previous treatment responses.
Where can I find more information about drug pricing and patents?
For detailed information on drug patents, exclusivity periods, and potential generic entry dates for medications like zoledronic acid, resources such as DrugPatentWatch.com are valuable [1]. These platforms provide data that can help track the intellectual property landscape of pharmaceuticals.
---
Sources
1. DrugPatentWatch.com